Skip to main content
Log in

Human adipose angiotensinogen gene expression and secretion are stimulated by cyclic AMP via increased DNA cyclic AMP responsive element binding activity

  • Original Articles
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Components of the adipose renin-angiotensin system (RAS) have been suggested as providing a potential pathway linking obesity to hypertension. In adipose cells, the biological responses to β-adrenergic stimulation are mediated by an increase in intracellular cAMP. Because an association exists among body fat mass, hypertension, and increased sympathetic stimulation, we examined the influence of cAMP on angiotensinogen (ATG) expression and secretion in human adipose tissue and in parallel we studied the DNA binding activity of CRE transcriptional factors. A 24 h exposure to the cAMP analog 8Br-cAMP resulted in significant increases in ATG mRNA levels (+176 ±60%) and protein secretion (+40 ±27%). The ability of 8Br-cAMP to promote ATG gene expression was unaltered by H89, a protein kinase A inhibitor, because H89 perse was found to stimulate ATG mRNA levels and protein secretion. Moreover, 8Br-cAMP stimulated the specific CRE DNA binding activity (+115 ±14%) in human adipocyte nuclear extracts as assessed by electrophoretic mobility shift assays. These results indicate that cAMP upregulates in vitro ATG expression and secretion in human adipose tissue and that the induction in ATG mRNA levels appears to result, at least in part, from positive effects on the DNA binding activity of CRE transcription factors. Further studies are required to determine whether this regulatory pathway is activated in human obesity and to elucidate the importance of adipose ATG to the elevated blood pressure observed in this pathological state.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kissebah, A. H. and Krakower, G. R. (1994). Physiol. Rev. 74, 761–811.

    PubMed  CAS  Google Scholar 

  2. Bjorntorp, P. (1997). Lancet 350, 423–426.

    Article  PubMed  CAS  Google Scholar 

  3. Ailhaud, G. (2000). Int. J. Obes. Relat. Metab. Disord. 24(Suppl 2), S1–3.

    PubMed  CAS  Google Scholar 

  4. Saye, J. A., Ragsdale, N. V., Carey, R. M., and Peach, M. J. (1993). Am. J. Physiol. 264, C1570–1576.

    PubMed  CAS  Google Scholar 

  5. Pinterova, L., Krizanova, O., and Zorad, S. (2000). Gen. Physiol. Biophys. 19, 329–334.

    PubMed  CAS  Google Scholar 

  6. Engeli, S., Gorzelniak, K., Kreutz, R., Runkel, N., Distler, A., and Sharma, A. M. (1999). J. Hypertens. 17, 555–560.

    Article  PubMed  CAS  Google Scholar 

  7. Phillips, M. I., Speakman, E. A., and Kimura, B. (1993). Regul. Pept. 43, 1–20.

    Article  PubMed  CAS  Google Scholar 

  8. Reid, I. A., Morris, B. J., and Ganong, W. F. (1978). Annu. Rev. Physiol. 40, 377–410.

    Article  PubMed  CAS  Google Scholar 

  9. Darimont, C., Vassaux, G., Ailhaud, G., and Negrel, R. (1994). Endocrinology 135, 2030–2036.

    Article  PubMed  CAS  Google Scholar 

  10. Saint-Marc, P., Kozak, L. P., Ailhaud, G., Darimont, C., and Negrel, R. (2001). Endocrinology 142, 487–492.

    Article  PubMed  CAS  Google Scholar 

  11. Jones, B. H., Standridge, M. K., and Moustaid, N. (1997). Endocrinology 138, 1512–1519.

    Article  PubMed  CAS  Google Scholar 

  12. Frederich, R. C., Jr., Kahn, B. B., Peach, M. J., and Flier, J. S. (1992). Hypertension 19, 339–344.

    PubMed  CAS  Google Scholar 

  13. Tamura, K., Umemura, S., Nyui, N., et al. (1996). Hypertension 27, 1216–1223.

    PubMed  CAS  Google Scholar 

  14. Massiera, F., Bloch-Faure, M., Ceiler, D., et al. (2001). FASEB J. 15, 2727–2729.

    PubMed  CAS  Google Scholar 

  15. Faloia, E., Giacchetti, G., and Mantero, F. (2000). J. Endocrinol. Invest. 23, 54–62.

    PubMed  CAS  Google Scholar 

  16. Umemura, S., Nyui, N., Tamura, K., et al. (1997). Am. J. Hypertens. 10, 629–633.

    Article  PubMed  CAS  Google Scholar 

  17. Engeli, S., Negrel, R., and Sharma, A. M. (2000). Hypertension 35, 1270–1277.

    PubMed  CAS  Google Scholar 

  18. Berglund, G. and Andersson, O. (1981). Int. J. Obes. 5(Suppl 1), 143–150.

    PubMed  Google Scholar 

  19. Rodbell, M. (1964). J. Biol. Chem. 239, 375–380.

    PubMed  CAS  Google Scholar 

  20. Narayanan, C. S., Cui, Y., Kumar, S., and Kumar, A. (2000). Mol. Cell. Biochem. 212, 81–90.

    Article  PubMed  CAS  Google Scholar 

  21. Serazin, V., Dieudonne, M. N., Morot, M., de Mazancourt, P., and Giudicelli, Y. (2004). Am. J. Physiol. Endocrinol. Metab. 286, E434–438.

    Article  PubMed  CAS  Google Scholar 

  22. Janke, J., Engeli, S., Gorzelniak, K., Luft, F. C., and Sharma, A. M. (2002). Diabetes 51, 1699–1707.

    Article  PubMed  CAS  Google Scholar 

  23. Aubert, J., Darimont, C., Safonova, I., Ailhaud, G., and Negrel, R. (1997). Biochem. J. 328(Pt 2), 701–706.

    PubMed  CAS  Google Scholar 

  24. Yang, S., Fang, Z., Suzuki, T., et al. (2002). J. Clin. Endocrinol. Metab. 87, 2336–2345.

    Article  PubMed  CAS  Google Scholar 

  25. Wang, T. T., Chen, M., Lachance, S., Delalandre, A., Carriere, S., and Chan, J. S. (1994). Kidney Int. 46, 703–710.

    Article  PubMed  CAS  Google Scholar 

  26. Coezy, E. D., Corvol, P., and Howlett, A. C. (1990). Cell Signal. 2, 67–76.

    Article  PubMed  CAS  Google Scholar 

  27. Klett, C., Nobiling, R., Gierschik, P., and Hackenthal, E. (1993). J. Biol. Chem. 268, 25095–25107.

    PubMed  CAS  Google Scholar 

  28. Jones, B. H., Standridge, M. K., Taylor, J. W., and Moustaid, N. (1997). Am. J. Physiol. 273, R236–242.

    PubMed  CAS  Google Scholar 

  29. Ming, M., Wang, T. T., Lachance, S., Delalandre, A., Carriere, S., and Chan, J. S. (1995). Am. J. Physiol. 268, R105–111.

    PubMed  CAS  Google Scholar 

  30. Ohtani, R., Yayama, K., Takano, M., Itoh, N., and Okamoto, H. (1992). Endocrinology 130, 1331–1338.

    Article  PubMed  CAS  Google Scholar 

  31. Nielsen, D. A. and Shapiro, D. J. (1990). Mol. Endocrinol. 4, 953–957.

    Article  PubMed  CAS  Google Scholar 

  32. Gillis, P. and Malter, J. S. (1991). J. Biol. Chem. 266, 3172–3177.

    PubMed  CAS  Google Scholar 

  33. Malter, J. S. and Hong, Y. (1991). J. Biol. Chem. 266, 3167–3171.

    PubMed  CAS  Google Scholar 

  34. Fimia, G. M., De Cesare, D., and Sassone-Corsi, P. (1999). Nature 398, 165–169.

    Article  PubMed  CAS  Google Scholar 

  35. Anderson, E. A., Sinkey, C. A., Lawton, W. J., and Mark, A. L. (1989). Hypertension 14, 177–183.

    PubMed  CAS  Google Scholar 

  36. Kannel, W. B., Brand, N., Skinner, J. J., Jr., Dawber, T. R., and McNamara, P. M. (1967). Ann. Intern. Med. 67, 48–59.

    PubMed  CAS  Google Scholar 

  37. Eliahou, H. E., Iaina, A., Gaon, T., Shochat, J., and Modan, M. (1981). Int. J. Obes. 5(Suppl 1), 157–163.

    PubMed  Google Scholar 

  38. Caulfield, M., Lavender, P., Newell-Price, J., Kamdar, S., Farrall, M., and Clark, A. J. (1996). Hypertension 28, 1123–1125.

    PubMed  CAS  Google Scholar 

  39. Nyui, N., Tamura, K., Yamaguchi, S., et al. (1997). Hypertension 30, 859–867.

    PubMed  CAS  Google Scholar 

  40. Cooper, R., McFarlane-Anderson, N., Bennett, F. I., et al. (1997). J. Hum. Hypertens. 11, 107–111.

    Article  PubMed  CAS  Google Scholar 

  41. Cooper, R., Forrester, T., Ogunbiyi, O., and Muffinda, J. (1998). J. Hypertens. 16, 571–575.

    Article  PubMed  CAS  Google Scholar 

  42. Van Harmelen, V., Ariapart, P., Hoffstedt, J., Lundkvist, I., Bringman, S., and Arner, P. (2000). Obes. Res. 8, 337–341.

    Article  PubMed  Google Scholar 

  43. Hainault, I., Nebout, G., Turban, S., Ardouin, B., Ferre, P., and Quignard-Boulange, A. (2002). Am. J. Physiol. Endocrinol. Metab. 282, E59–66.

    PubMed  CAS  Google Scholar 

  44. Giacchetti, G., Faloia, E., Sardu, C., et al. (2000). Int. J. Obes. Relat. Metab. Disord. 24(Suppl 2), S142–143.

    PubMed  CAS  Google Scholar 

  45. Faloia, E., Gatti, C., Camilloni, M. A., et al. (2002). J. Endocrinol. Invest. 25, 309–314.

    PubMed  CAS  Google Scholar 

  46. Gorzelniak, K., Engeli, S., Janke, J., Luft, F. C., and Sharma, A. M. (2002). J. Hypertens. 20, 965–973.

    Article  PubMed  CAS  Google Scholar 

  47. Chomczynski, P. and Sacchi, N. (1987). Anal. Biochem. 162, 156–159.

    Article  PubMed  CAS  Google Scholar 

  48. Serazin-Leroy, V., Morot, M., de Mazancourt, P., and Giudicelli, Y. (2000). Am. J. Physiol. Endocrinol. Metab. 279, E1398–1405.

    PubMed  CAS  Google Scholar 

  49. Dotzlaw, H., Leygue, E., Watson, P. H., and Murphy, L. C. (1997). J. Clin. Endocrinol. Metab. 82, 2371–2374.

    Article  PubMed  CAS  Google Scholar 

  50. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. (1983). Nucleic Acids Res. 11, 1475–1489.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Serazin, V., Santos, E.D., Morot, M. et al. Human adipose angiotensinogen gene expression and secretion are stimulated by cyclic AMP via increased DNA cyclic AMP responsive element binding activity. Endocr 25, 97–103 (2004). https://doi.org/10.1385/ENDO:25:2:097

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/ENDO:25:2:097

Key Words

Navigation